Dysregulation of TTN Gene Expression, Titin Protein Levels, and Circulating ncRNAs (miR-200a, lncRNA FOXD2-AS1, and snoRNA-42) in Dilated Cardiomyopathy: A Pilot Study
Abstract
Dilated Cardiomyopathy is the major cause of congestive heart failure and sudden cardiac death. It is a type of cardiomyopathy characterized by ventricular dilatation, wall thinning and systolic dysfunction. TTN gene is implicated in DCM and encodes for giant titin protein. This study explores the association between TTN gene expression with some types of non-coding RNAs in DCM patients. The study comprised three age- and sex-matched groups (20 individuals each): healthy controls, male patients, and female patients. Relative expression levels of TTN, miR-200a, lncRNA FOXD2-AS1, and snoRNA-42 were quantified using qRT-PCR, whereas serum titin protein levels were measured via ELISA. TTN gene expression was significantly elevated in both male and female DCM patients compared with controls (P<0.001). Furthermore, miR-200a and snoRNA-42 levels were also significantly increased in DCM patients particularly in females. In contrast, lncRNA FOXD2-AS1 was significantly decreased in both sexes of DCM patients. ROC curve analysis for TTN gene demonstrated high diagnostic performance, sensitivity and specificity with (P=0.0022), supporting TTN as a reliable molecular biomarker for DCM. Similarly, miR-200a showed strong diagnostic potential, particularly in females (P=0.0275 in males and P=0.0022 in females), underscoring its efficiency as a sex-specific biomarker. Furthermore, Titin protein level was significantly elevated in DCM patients, particularly in females. Pearson correlation analysis detected a negative correlation between miR-200a and TTN mRNA in both males and females, negative correlations were also observed between miR-200a and titin protein levels. In contrast, TTN gene expression and titin protein levels showed a positive correlation, indicating transcription-driven increases in titin level. To the best of our knowledge, this is the first study in Iraq, particularly in Mosul, to integrate Titin protein and TTN gene expression with multiple circulating ncRNA classes (miR-200a, lncRNA FOXD2-AS1 and snoRNA-42) in patients with DCM. The combined analysis of TTN gene / Titin protein axis and ncRNAs within a clinical group from Mosul city provides a comprehensive view of post-transcriptional regulation and revealed sex-dependent molecular differences. Moreover, the strong diagnostic performance of TTN and miR-200a supports their potential as non-invasive biomarkers for DCM. By focusing on a Middle Eastern population, this study contributes novel region-specific molecular data and expands current understanding of DCM beyond previously studied populations. In DCM patients the expression level of TTN gene was significantly increased, demonstrating that transcriptional activation was correlated with myocardial remodeling. The dysregulated expression of ncRNAs (miR-200a, lncRNA FOXD2-AS1 and snoRNA-42), suggested the existence of a complex post-transcriptional regulatory network affecting TTN expression. All of these findings highlight the potential of TTN and ncRNA signatures as promising non-invasive molecular biomarkers for DCM.
2. Hameed MA, Hamed OM. Detection of P53 suppressor gene mutation in women with breast cancer in Mosul city. AIP Conf Proc 2023;2834:020007.
3. Hamed OM. Analysis of Common Mutation of P53 Gene in Male with Lung Cancer in Mosul City. Bionatura 2022;7:52.
4. Ware JS, Cook SA. Role of titin in cardiomyopathy: From DNA variants to patient stratification. Nat Rev Cardiol 2018;15:241–52.
5. Herman DS, Lam L, Taylor MRG, Wang L, Christodoulou D, Conner L, et al. Truncations of Titin Causing Dilated Cardiomyopathy. N Engl J Med 2012;366:619–28.
6. Younis MM, Attash SM, Hamed OM. Detecting the Role of mi RNA Molecules and Methylation on Expression of BMAL1 Gene in Kids with Amyloid Leukemia in Mosul City. Texila Adv J Multidiscip Health Res 2025;05:Art016.
7. Carabetta N, Siracusa C, Leo I, Panuccio G, Strangio A, Sabatino J, et al. Cardiomyopathies: The Role of Non-Coding RNAs. Non-coding RNA 2024;10:0053.
8. Wang L, Zhu L, Luan R, Wang L, Fu J, Wang X, et al. Analyzing gene expression profiles in dilated cardiomyopathy via bioinformatics methods. Braz J Med Biol Res 2016;49:e4897.
9. Magenta A, Ciarapica R, Capogrossi MC. The Emerging Role of MIR-200 Family in Cardiovascular Diseases. Circ Res 2017;120:1399-402.
10. Al-Hassani OMH. Role of MTHFR C667T and MTRR A66G genes polymorphism with thyroid disorders. J Phys Conf Ser 2020;1660:012007.
11. Zhang Y, Zhang M, Xu W, Chen J, Zhou X. The long non-coding RNA H19 promotes cardiomyocyte apoptosis in dilated cardiomyopathy. Oncotarget 2017;8:28588-94.
12. Jha S, Kanth V, Loganathbabu T, Kumaran K, Krishnasamy G, Aruljothi KN. Long Non-Coding RNAs (lncRNAs) in Heart Failure: A Comprehensive Review. Non-coding RNA 2023;9:0032.
13. Li Y, Chen X, Xiao S, Wang H, Li B, Zhang MH, et al. Unlocking the life code: a review of SnoRNA functional diversity and disease relevance. Cell Commun Signal 2025;23:18.
14. Loescher CM, Hobbach AJ, Linke WA. Titin (TTN): from molecule to modifications, mechanics, and medical significance. Cardiovasc Res 2022;118:2903-18.
15. Van Der Pijl R, Nusayr E, Strom J, Slater R, Gohlke J, Hourani Z, et al. Importance of N2BA Titin in Maintaining Cardiac Homeostasis and Its Role in Dilated Cardiomyopathy. Circ Heart Fail 2025;18:311-24.
16. Khudher S, Hamed OM. The effect of non-coding RNA genes on the gene expression of MLH1 gene in patients with lung cancer. Health Biotechnol Biopharma 2025;9:1-13.
17. Stöhr EJ, Takayama H, Ferrari G. Stretch your heart—but not too far: The role of titin mutations in dilated cardiomyopathy. J Thorac Cardiovasc Surg 2018;155:209-14.
18. You P, Chen H, Han W, Deng J. miR-200a-3p overexpression alleviates diabetic cardiomyopathy injury in mice by regulating autophagy through the FOXO3/Mst1/Sirt3/AMPK axis. Peer J 2023;11:e15840.
19. Sun X, Zuo H, Liu C, Yang Y. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis. Int J Mol Med 2016;38:1303–11.
20. Ma Y, Pan C, Tang X, Zhang M, Shi H, Wang T, et al. MicroRNA-200a represses myocardial infarction-related cell death and inflammation by targeting the Keap1/Nrf2 and β-catenin pathways. Hellenic J Cardiol 2021;62:139-48.
21. Sun X, Wang G, Luo W, Gu H, Ma W, Wei X, et al. Small but strong: the emerging role of small nucleolar RNA in cardiovascular diseases. Front Cell Dev Biol 2023;11:1292925.
22. Jagielski NP, Rai AK, Rajan KS, Mangal V, Garikipati VNS. A contemporary review of snoRNAs in cardiovascular health: RNA modification and beyond. Mol Ther Nucleic Acids 2024;35:102087.
23. Le LTT, Nhu CXT. The Role of Long Non-Coding RNAs in Cardiovascular Diseases. Int J Mol Sci 2023;24:13805.
24. Kong YW, Cannell IG, De Moor CH, Hill K, Garside PG, Hamilton TL, et al. The mechanism of micro-RNA-mediated translation repression is determined by the promoter of the target gene. Proc Natl Acad Sci U S A 2008;105:13724–9.
25. Argirò A, Ho C, Day SM, van der Velden J, Cerbai E, Saberi S, et al. Sex-Related Differences in Genetic Cardiomyopathies. J Am Heart Assoc 2022;11:e024947.
26. O’Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 2018;9:402.
| Files | ||
| Issue | Vol 64 No 9 (2026) | |
| Section | Original Articles | |
| DOI | https://doi.org/10.18502/acta.v64i9.22954 | |
| Keywords | ||
| DCM TTN miRNA-200a lncRNA FOXD2-AS1 snoRNA-42 Titin protein | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |


